Oxytocin Structure: The Molecular Biology of the Love Hormone

Oxytocin is remarkably small – just nine amino acids – yet it ranks among the most powerful signalling molecules in the human body. This single peptide can trigger labour contractions, stimulate milk ejection, strengthen social bonds, and modulate trust. Understanding the oxytocin structure at the molecular level reveals why such a tiny molecule carries such outsized biological significance, and why it has fascinated biochemists since the 1950s.

On this page we walk through the oxytocin chemical formula, its amino acid sequence, the three-dimensional shape that governs receptor binding, and the subtle structural differences that separate oxytocin from its close cousin vasopressin.

Chemical Formula and Molecular Weight

The oxytocin formula is C₄₃H₆₆N₁₂O₁₂S₂. In plain terms, every molecule of oxytocin contains 43 carbon atoms, 66 hydrogen atoms, 12 nitrogen atoms, 12 oxygen atoms, and – critically – two sulfur atoms that form the disulfide bridge holding its ring structure together.

• Molecular formula: C₄₃H₆₆N₁₂O₁₂S₂
• Molecular weight: 1,007.19 Da (daltons)
• CAS registry number: 50-56-6
• PubChem CID: 439302
• IUPAC classification: cyclic nonapeptide hormone

At just over 1,000 daltons, oxytocin sits at the boundary between small molecules and proteins. It is large enough to adopt a defined three-dimensional conformation, yet small enough that Vincent du Vigneaud was able to achieve its total chemical synthesis in 1953 – a feat that earned him the Nobel Prize in Chemistry.

The two sulfur atoms in the oxytocin chemical formula deserve special attention. They belong to the two cysteine residues at positions 1 and 6 of the peptide chain, and they form a covalent disulfide bond (–S–S–) that locks the first six amino acids into a ring. Without this bond, oxytocin would be a floppy linear chain with no biological activity.

The Nine Amino Acids

Oxytocin is a nonapeptide – a peptide built from nine amino acids. Its primary sequence, written from the amino terminus (N-terminus) to the carboxy terminus (C-terminus), is:

Cys¹ – Tyr² – Ile³ – Gln⁴ – Asn⁵ – Cys⁶ – Pro⁷ – Leu⁸ – Gly⁹-NH₂

In single-letter amino acid code, this reads CYIQNCPLG-NH₂. Each residue plays a specific role in the molecule’s structure and function:

• Cysteine (Cys¹) – Provides one half of the disulfide bridge. Its thiol side chain bonds covalently to Cys⁶.
• Tyrosine (Tyr²) – A bulky aromatic residue whose hydroxyl-bearing phenol ring contributes to receptor recognition. Studies by Manning and colleagues (1995) showed that modifications to Tyr² substantially reduce oxytocin receptor binding.
• Isoleucine (Ile³) – A branched-chain hydrophobic amino acid. This is one of the two positions where oxytocin differs from vasopressin (which has phenylalanine here instead).
• Glutamine (Gln⁴) – Contributes a polar amide side chain that helps stabilise hydrogen bonds within the ring.
• Asparagine (Asn⁵) – Another polar residue, important for the correct folding of the cyclic portion.
• Cysteine (Cys⁶) – Completes the disulfide bond with Cys¹, creating the 20-membered tocin ring that is essential for biological activity.
• Proline (Pro⁷) – An imino acid whose rigid cyclic side chain introduces a sharp bend between the ring and the tail, acting as a structural hinge.
• Leucine (Leu⁸) – A hydrophobic residue in the linear tail. This is the second position distinguishing oxytocin from vasopressin (which has arginine here).
• Glycine (Gly⁹-NH₂) – The smallest amino acid, located at the C-terminus. Crucially, it carries an amide group (–NH₂) rather than the usual free carboxyl (–COOH). This amidated C-terminus is required for full biological potency.

The Cys¹–Cys⁶ disulfide bond is the defining structural feature of the oxytocin molecule. This covalent sulfur–sulfur bridge closes the first six residues into a rigid ring, while residues 7–9 extend as a flexible linear tail. The combination of a constrained ring and a mobile tail is the hallmark of the entire oxytocin/vasopressin peptide superfamily.

Ring and Tail: The 3D Structure

The oxytocin molecular structure divides naturally into two regions: a cyclic hexapeptide ring and a linear tripeptide tail.

The Cyclic Ring (Positions 1–6)

The disulfide bond between Cys¹ and Cys⁶ closes a 20-atom ring. This ring is relatively rigid and presents a defined surface for receptor interaction. NMR studies by Bhaskaran and colleagues (1992) showed that the ring adopts a saddle-like conformation with two β-turns, creating a compact structure even in the absence of a receptor.

The Linear Tail (Positions 7–9)

The tripeptide tail (Pro–Leu–Gly-NH₂) extends from the ring and is more flexible. Proline at position 7 creates a kink that projects the tail away from the ring plane. This tail makes initial contacts with the oxytocin receptor, acting as a “recognition antenna” before the ring docks into the binding pocket.

A Simplified Structural Diagram

        S ― S
       /     
  Cys¹       Cys⁶
   |           |
  Tyr²       Asn⁵          RING
   |           |        (positions 1–6)
  Ile³ ― Gln⁴
                
                Pro⁷
                 |          TAIL
                Leu⁸    (positions 7–9)
                 |
                Gly⁹–NH₂
  

This architecture – a disulfide-bridged ring with a short linear extension – is shared by all members of the oxytocin/vasopressin superfamily, from fish isotocin to mammalian vasopressin. It represents one of the oldest conserved peptide structures in vertebrate evolution.

Oxytocin vs Vasopressin: A Two-Amino-Acid Difference

Oxytocin and arginine vasopressin (AVP) are strikingly similar. Of nine amino acid positions, the two peptides differ at only two:

Position	Oxytocin	Vasopressin (AVP)
3	Isoleucine (Ile)	Phenylalanine (Phe)
8	Leucine (Leu)	Arginine (Arg)

These two substitutions – swapping one hydrophobic residue for another at position 3 (Ile→Phe), and replacing a hydrophobic leucine with a positively charged arginine at position 8 (Leu→Arg) – are enough to create profoundly different biological functions. Oxytocin drives uterine contraction, milk ejection, and social bonding; vasopressin regulates water retention, blood pressure, and certain aspects of aggression and territorial behaviour.

The position-8 change is particularly significant. Arginine’s positive charge in vasopressin alters the peptide’s interaction with V1a, V1b, and V2 vasopressin receptors, steering it toward renal and cardiovascular targets. Leucine in oxytocin keeps the tail hydrophobic, favouring the structurally distinct oxytocin receptor (OXTR).

Evolutionary Divergence

The oxytocin and vasopressin lineages diverged from a single ancestral gene approximately 500 million years ago, likely through a gene duplication event in early jawed vertebrates. Research by Gwee and colleagues (2009) traced this split to the emergence of gnathostomes, finding that the ancestral peptide – vasotocin – still exists in lampreys and other jawless fish. After the duplication, the two copies diverged to take on specialised roles: one lineage gave rise to oxytocin-like peptides (involved in reproduction), and the other to vasopressin-like peptides (involved in water balance).

This deep evolutionary conservation underscores just how fundamental the nonapeptide structure is to vertebrate physiology. Five hundred million years of natural selection have preserved the core ring-and-tail architecture while fine-tuning individual residues for specific receptor interactions.

The Oxytocin Receptor (OXTR)

The oxytocin receptor is the protein through which the oxytocin peptide exerts its effects on cells. It belongs to the rhodopsin-type (class A) family of G-protein coupled receptors (GPCRs) – the largest superfamily of membrane receptors in the human genome.

• Gene: OXTR
• Chromosomal location: 3p25.3 (short arm of chromosome 3)
• Protein length: 389 amino acids
• Transmembrane domains: 7 (the hallmark of GPCRs)
• Primary signalling pathway: Gq/11 → phospholipase C → intracellular calcium release

Distribution

OXTR is expressed widely in both the brain and peripheral tissues. In the central nervous system, it is found in regions crucial for social behaviour and emotional regulation, including the amygdala, hypothalamus, nucleus accumbens, hippocampus, and prefrontal cortex. Peripherally, oxytocin receptors are concentrated in the uterine myometrium (where they mediate labour contractions), mammary gland myoepithelial cells (milk ejection), and the heart.

The rs53576 Polymorphism

One of the most studied genetic variants in the OXTR gene is the single nucleotide polymorphism rs53576 (a G→A substitution in the third intron). Research by Rodrigues and colleagues (2009) found that individuals carrying the GG genotype scored higher on measures of empathy and stress reactivity compared to A-allele carriers. Tost and colleagues (2010) further showed that rs53576 influences the structure and function of the hypothalamus and amygdala, suggesting a biological mechanism through which this variant shapes social behaviour.

While these findings are intriguing, it is important to note that single polymorphisms explain only a small fraction of behavioural variation, and the field continues to debate the replicability and effect size of rs53576 associations.

Du Vigneaud’s Nobel Prize: The First Peptide Hormone Synthesised

The story of oxytocin’s chemical structure is inseparable from the career of American biochemist Vincent du Vigneaud (1901–1978). Working at Cornell University Medical College, du Vigneaud spent years studying sulfur-containing biological compounds – from insulin to the amino acid methionine – before turning his attention to the posterior pituitary hormones.

In the early 1950s, du Vigneaud’s group determined the complete amino acid sequence of oxytocin, confirming it as a nine-residue peptide with an intramolecular disulfide bond. In 1953, they achieved the total chemical synthesis of oxytocin – assembling it amino acid by amino acid in the laboratory and demonstrating that the synthetic product was identical to the natural hormone in every biological assay. This was the first time any peptide hormone had been synthesised, a landmark achievement in biochemistry.

Du Vigneaud was awarded the Nobel Prize in Chemistry in 1955 “for his work on biochemically important sulphur compounds, especially for the first synthesis of a polypeptide hormone.” The Nobel citation recognised not just the technical feat of synthesis, but its broader significance: it proved that complex biological activity could arise from a defined chemical structure, bridging the gap between organic chemistry and physiology.

Du Vigneaud went on to synthesise vasopressin and numerous analogues of both hormones, laying the foundation for modern peptide pharmacology. His collaborator Iphigenia Photaki extended these methods to produce further synthetic variants, including deamido-oxytocin, in the years that followed.

Oxytocin Across Species: 500 Million Years of Conservation

The oxytocin molecule is not unique to mammals. Closely related peptides – collectively known as the oxytocin/vasopressin superfamily – exist throughout the vertebrate lineage and even in some invertebrates. All share the same fundamental structure: nine amino acids, a Cys¹–Cys⁶ disulfide ring, and an amidated C-terminus.

Key Homologues

• Vasotocin – Found in jawless fish (lampreys, hagfish), amphibians, reptiles, and birds. This is considered the ancestral molecule from which both oxytocin and vasopressin evolved. Its sequence: Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH₂.
• Isotocin – The oxytocin homologue in bony fish (teleosts). It differs from oxytocin at positions 4 and 8 (Ser⁴ and Ser⁸ in place of Gln and Leu). Research by Goodson and Bass (2001) demonstrated that isotocin modulates social approach behaviour in fish, paralleling oxytocin’s role in mammals.
• Mesotocin – Found in marsupials, birds, reptiles, and amphibians. It differs from oxytocin only at position 8 (Ile instead of Leu), making it the closest known homologue. Studies in chickens and zebra finches have linked mesotocin to pair bonding and parental behaviour.
• Annetocin – Discovered in the earthworm Eisenia foetida by Oumi and colleagues (1996), this was one of the first invertebrate members of the superfamily to be identified, demonstrating that the oxytocin-like signalling system predates the vertebrate lineage.

The extraordinary conservation of this peptide family – maintaining the same nine-residue, disulfide-bridged architecture across more than 500 million years of evolution – suggests that it serves functions so fundamental to animal life that natural selection has tolerated almost no variation in the core structure. From regulating egg-laying in worms to facilitating mother–infant bonding in humans, the oxytocin molecule has been repurposed and refined, but never fundamentally redesigned.

Frequently Asked Questions